Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Ahmed A, Kolkailah"'
Autor:
Ahmed A. Kolkailah, MD, MSc, Talal Asif, MD, Fady H. Iskander, MD, MSc, Javier Gomez-Valencia, MD, MSc, FACC, Saurabh Malhotra, MD, MPH, FACC
Publikováno v:
Radiology Case Reports, Vol 17, Iss 9, Pp 3270-3273 (2022)
We report a case of a 44-year-old man with a clinical history of Tetralogy of Fallot status post staged surgical correction with mechanical pulmonic valve replacement who presented with progressive exertional dyspnea in the setting of non-compliance
Externí odkaz:
https://doaj.org/article/eb6a5807fe3c403f90168424462efac4
Autor:
Ann Marie Navar, Ahmed A. Kolkailah, Robert Overton, Nishant P. Shah, Justin F. Rousseau, Greg C. Flaker, Michael P. Pignone, Eric D. Peterson
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 22 (2022)
Background Among patients with nonvalvular atrial fibrillation (AF) and an elevated stroke risk, guidelines recommend direct oral anticoagulants (DOACs) over warfarin for stroke prevention. Changes in DOAC use over the past decade have not been well
Externí odkaz:
https://doaj.org/article/85642bbcdc2146d6bf90696bf8410ad9
Autor:
Matthew W. Segar, Kershaw V. Patel, Anne S. Hellkamp, Muthiah Vaduganathan, Yuliya Lokhnygina, Jennifer B. Green, Siu‐Hin Wan, Ahmed A. Kolkailah, Rury R. Holman, Eric D. Peterson, Vaishnavi Kannan, Duwayne L. Willett, Darren K. McGuire, Ambarish Pandey
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 11 (2022)
Background The WATCH‐DM (weight [body mass index], age, hypertension, creatinine, high‐density lipoprotein cholesterol, diabetes control [fasting plasma glucose], ECG QRS duration, myocardial infarction, and coronary artery bypass grafting) and T
Externí odkaz:
https://doaj.org/article/a89de53f91a34889b6de8499d92d2926
Debunking the July Effect in Transcatheter Interventions in Structural Heart Disease: Truth or Myth?
Autor:
Sameer A. Hirji, MD, MPH, Supreet Singh, MD, Alexis K. Okoh, MD, Alexandra Malarczyk, BS, Edward D. Percy, MD, Morgan T. Harloff, MD, Ahmed A. Kolkailah, MD, MSc, Cheryl K. Zogg, MSPH, MHS, PhD, Emefah Loccoh, MD, Farhang Yazdchi, MD, Mark J. Russo, MD, Patrick O'Gara, MD, Pinak Shah, MD, Tsuyoshi Kaneko, MD
Publikováno v:
Structural Heart, Vol 6, Iss 1, Pp 100001- (2022)
Background: The “July effect”, the perception of worse outcomes in the first month of training, has been previously demonstrated in critical care medicine and general surgery. However, the July effect in the context of structural heart interventi
Externí odkaz:
https://doaj.org/article/6d030ece049d462e9ac31d0dc5f54cc2
Autor:
Ahmed A. Kolkailah, Marwan S. Abougergi, Parth V. Desai, Axi Patel, Setri Fugar, Alexis K. Okoh, Ahmed Al-Ogaili, Sameer A. Hirji, Tsuyoshi Kaneko, Annabelle Santos Volgman, Rami Doukky, Justin L. Grodin, Darren K. McGuire
Publikováno v:
American Heart Journal Plus, Vol 13, Iss , Pp 100072- (2022)
Introduction: The “July effect” refers to the potential of adverse clinical outcomes related to the annual turnover of trainees. We investigated whether this impacts inpatient heart failure (HF) outcomes. Methods: Data from all adults (≥18 year
Externí odkaz:
https://doaj.org/article/a3e28d22e20c418b95c422c78f797435
Publikováno v:
JAMA cardiology.
ImportanceRecent national guidelines recommend sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagonlike peptide-1 receptor agonists (GLP-1 RA) in patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD); yet,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3efd7047b173bb9adc39b5c0ad941b4
https://pubmed.ncbi.nlm.nih.gov/36322056
https://pubmed.ncbi.nlm.nih.gov/36322056
Autor:
Ahmed A. Kolkailah, Ildiko Lingvay, Idit Dobrecky‐Mery, Alona Aharonovich, Jens‐Peter David, Cecilie Holse, Søren Rasmussen, Darren K. McGuire
Publikováno v:
Diabetes, Obesity and Metabolism. 25:1117-1120
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0e75fffa7ea4fd1db9e546e3bce862c
https://doi.org/10.1111/dom.14941
https://doi.org/10.1111/dom.14941
Autor:
Adam J, Nelson, Josephine L, Harrington, Ahmed A, Kolkailah, Neha J, Pagidipati, Darren K, McGuire
Publikováno v:
Heart Failure Clinics. 18:597-607
Sodium-glucose cotransporter-2 inhibitors (SGLT-2i) improve the risk for heart and kidney failure. However, their effects on major atherosclerotic cardiovascular events (MACE) are less clear. Although outcomes trials of drugs for diabetes were not po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b84527a9e16498c36f153b5706bfc01
https://doi.org/10.1016/j.hfc.2022.03.007
https://doi.org/10.1016/j.hfc.2022.03.007
Publikováno v:
Current Atherosclerosis Reports. 24:607-617
To review the current evidence regarding the impact of the coronavirus disease 2019 (COVID-19) pandemic on cardiometabolic health, with a focus on strategies to help mitigate adverse effects on population health.Individuals with cardiometabolic disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c824946af47dd612fe772ca156cb606d
https://doi.org/10.1007/s11883-022-01033-7
https://doi.org/10.1007/s11883-022-01033-7
Autor:
Eric J. Hall, Colby R. Ayers, Ahmed A. Kolkailah, Christine Rutan, Jason Walchok, Joseph H. Williams, Tracy Y. Wang, Fatima Rodriguez, Steven M. Bradley, Laura Stevens, Jennifer L. Hall, Pratheek Mallya, Gregory A. Roth, David A. Morrow, Mitchell S.V. Elkind, Sandeep R. Das, James A. de Lemos
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 16
Background: The COVID-19 pandemic has evolved through multiple phases characterized by new viral variants, vaccine development, and changes in therapies. It is unknown whether rates of cardiovascular disease (CVD) risk factor profiles and complicatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b84c24f3b581ad693aa393049ccfbe6c
https://doi.org/10.1161/circoutcomes.122.009652
https://doi.org/10.1161/circoutcomes.122.009652